DE69110101D1 - GIP-Analoge und deren Verwendung. - Google Patents

GIP-Analoge und deren Verwendung.

Info

Publication number
DE69110101D1
DE69110101D1 DE69110101T DE69110101T DE69110101D1 DE 69110101 D1 DE69110101 D1 DE 69110101D1 DE 69110101 T DE69110101 T DE 69110101T DE 69110101 T DE69110101 T DE 69110101T DE 69110101 D1 DE69110101 D1 DE 69110101D1
Authority
DE
Germany
Prior art keywords
lys
asn
gip
homoserine
analogues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69110101T
Other languages
English (en)
Other versions
DE69110101T2 (de
Inventor
Masayasu Kurono
Takahiko Mitani
Haruo Takahashi
Ryoichi Unno
Tomoo Suzuki
Yuji Hayashi
Yohei Kobayashi
Yoko Ishii
Kiichi Sawai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanwa Kagaku Kenkyusho Co Ltd
Original Assignee
Sanwa Kagaku Kenkyusho Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanwa Kagaku Kenkyusho Co Ltd filed Critical Sanwa Kagaku Kenkyusho Co Ltd
Publication of DE69110101D1 publication Critical patent/DE69110101D1/de
Application granted granted Critical
Publication of DE69110101T2 publication Critical patent/DE69110101T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Holo Graphy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69110101T 1990-10-05 1991-09-30 GIP-Analoge und deren Verwendung. Expired - Fee Related DE69110101T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2266438A JPH04145099A (ja) 1990-10-05 1990-10-05 Ｇｉｐ様活性を有するポリペプチド誘導体及びその用途

Publications (2)

Publication Number Publication Date
DE69110101D1 true DE69110101D1 (de) 1995-07-06
DE69110101T2 DE69110101T2 (de) 1996-02-29

Family

ID=17430941

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69110101T Expired - Fee Related DE69110101T2 (de) 1990-10-05 1991-09-30 GIP-Analoge und deren Verwendung.

Country Status (6)

Country Link
EP (1) EP0479210B1 (de)
JP (1) JPH04145099A (de)
AT (1) ATE123296T1 (de)
DE (1) DE69110101T2 (de)
DK (1) DK0479210T3 (de)
ES (1) ES2076437T3 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ258824A (en) * 1992-12-16 1997-11-24 Univ Melbourne Nucleic acid encoding type ii serine proteinase inhibitor precursor and its use
EP1119625B1 (de) * 1998-10-07 2005-06-29 Medical College Of Georgia Research Institute, Inc. Glukose-abhängiges, insulinotropisches peptid für die verwendung als osteotropes hormon
US20050272652A1 (en) 1999-03-29 2005-12-08 Gault Victor A Peptide analogues of GIP for treatment of diabetes, insulin resistance and obesity
KR20020097236A (ko) * 2000-04-27 2002-12-31 바이오네브라스카, 인코포레이티드 타입-2 당뇨병, 내당능 장애, 또는 공복 혈당 장애에 대한감수성을 검출하기 위한 위억제성 폴리펩티드 진단 시험
AU2003237933A1 (en) * 2002-06-11 2003-12-22 Cellartis Ab Use of compounds having gip activity for the treatment of disorders associated with abnormal loss of cells and/or for the treatment of obesity
WO2006045796A2 (en) 2004-10-25 2006-05-04 Cytos Biotechnology Ag Gastric inhibitory polypeptide (gip) antigen arrays and uses thereof
US8263545B2 (en) 2005-02-11 2012-09-11 Amylin Pharmaceuticals, Inc. GIP analog and hybrid polypeptides with selectable properties
CA2597649A1 (en) 2005-02-11 2006-08-17 Amylin Pharmaceuticals, Inc. Gip analog and hybrid polypeptides with selectable properties
WO2007056362A2 (en) 2005-11-07 2007-05-18 Indiana University Research And Technology Corporation Glucagon analogs exhibiting physiological solubility and stability
EP2124974B1 (de) 2007-01-05 2017-03-15 Indiana University Research and Technology Corporation Glocagonanaloga mit erhöhter löslichkeit in physiologischen ph-puffern
CN101790538B (zh) 2007-02-15 2014-07-30 印第安纳大学研究与科技公司 胰高血糖素/glp-1受体共激动剂
JP5771005B2 (ja) 2007-10-30 2015-08-26 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ グルカゴンアンタゴニスト及びｇｌｐ−１アゴニスト活性を示す化合物
JP5669582B2 (ja) 2007-10-30 2015-02-12 インディアナ ユニバーシティー リサーチ アンド テクノロジー コーポレーションＩｎｄｉａｎａ Ｕｎｉｖｅｒｓｉｔｙ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｒｐｏｒａｔｉｏｎ グルカゴンアンタゴニスト
CN104447980A (zh) 2008-06-17 2015-03-25 印第安纳大学研究及科技有限公司 在生理pH缓冲液中具有增强的溶解性和稳定性的胰高血糖素类似物
PE20100056A1 (es) 2008-06-17 2010-01-26 Univ Indiana Res & Tech Corp Analogos de glucagon como agonistas gip
EP2300037B1 (de) 2008-06-17 2016-03-30 Indiana University Research and Technology Corporation Coagonisten des glucagon/glp-1 rezeptors
US9072703B2 (en) * 2008-08-07 2015-07-07 Ipsen Pharma S.A.S. Glucose-dependent insulinotropic polypeptide analogues
EA020019B1 (ru) 2008-08-07 2014-08-29 Ипсен Фарма С.А.С. Аналоги глюкозозависимого инсулинотропного полипептида
RU2550696C2 (ru) 2008-12-19 2015-05-10 Индиана Юниверсити Рисерч Энд Текнолоджи Корпорейшн Основанные на амидах пролекарства пептидов глюкагонового надсемейства
SG176858A1 (en) 2009-06-16 2012-02-28 Univ Indiana Res & Tech Corp Gip receptor-active glucagon compounds
WO2011075393A2 (en) 2009-12-18 2011-06-23 Indiana University Research And Technology Corporation Glucagon/glp-1 receptor co-agonists
US8551946B2 (en) 2010-01-27 2013-10-08 Indiana University Research And Technology Corporation Glucagon antagonist-GIP agonist conjugates and compositions for the treatment of metabolic disorders and obesity
CN103179976A (zh) 2010-05-13 2013-06-26 印第安纳大学研究及科技有限公司 呈现g蛋白偶联受体活性的胰高血糖素超家族肽
CN103079587B (zh) 2010-05-13 2016-05-11 印第安纳大学研究及科技有限公司 呈现核激素受体活性的胰高血糖素超家族肽
CA2796894A1 (en) 2010-06-24 2011-12-29 Indiana University Research And Technology Corporation Amide based glucagon superfamily peptide prodrugs
ES2713952T3 (es) 2010-12-22 2019-05-24 Univ Indiana Res & Tech Corp Análogos de glucagón que muestran actividad de receptor de GIP
EP2718317B1 (de) * 2011-06-10 2018-11-14 Beijing Hanmi Pharmaceutical Co., Ltd. Glukoseabhängige insulinotrope polypeptid-analoga, pharmazeutische zusammensetzungen daraus und ihre verwendung
GEP20176629B (en) 2011-06-22 2017-02-27 Indiana Unversity Research And Tech Corporation Glucagon/glp-1 receptor co-agonists
JP6184404B2 (ja) 2011-06-22 2017-08-23 インディアナ ユニヴァーシティ リサーチ アンド テクノロジー コーポレイション グルカゴン／ｇｌｐ−１レセプターコアゴニスト
KR20140097151A (ko) 2011-11-17 2014-08-06 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 글루코코르티코이드 수용체 활성을 나타내는 글루카곤 슈퍼패밀리 펩티드
TWI599575B (zh) 2012-06-21 2017-09-21 印第安納大學科技研究公司 表現ｇｉｐ受體活性之胰高血糖素類似物
FR2994848B1 (fr) 2012-08-30 2014-08-22 Univ Paris Curie Traitement de l'arthrose par les hormones incretines ou leurs analogues
JOP20180028A1 (ar) 2017-03-31 2019-01-30 Takeda Pharmaceuticals Co مركب ببتيد

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01153092A (ja) * 1986-11-27 1989-06-15 Sanwa Kagaku Kenkyusho Co Ltd ヒトガストリツクインヒビトリポリペプチド（ＧＩＰ）前駆体のｃＤＮＡクロ−ン

Also Published As

Publication number Publication date
EP0479210A2 (de) 1992-04-08
EP0479210B1 (de) 1995-05-31
EP0479210A3 (en) 1992-09-02
ES2076437T3 (es) 1995-11-01
JPH04145099A (ja) 1992-05-19
DK0479210T3 (da) 1995-07-31
ATE123296T1 (de) 1995-06-15
DE69110101T2 (de) 1996-02-29

Similar Documents

Publication Publication Date Title
DE69110101D1 (de) GIP-Analoge und deren Verwendung.
ATE101619T1 (de) Vip-analogen und ihre verwendung.
DK0434385T3 (da) Anvendelse af makrocycliske, nitroholdige forbindelser til behandling af retrovirale infektioner
DE59010349D1 (de) Aminoalkohole
ES2071815T3 (es) Analogos de delecion de los peptidos conocidos como magaininas.
GR3029406T3 (en) Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them.
ATE122385T1 (de) Azeotrope oder azeotropähnliche zusammensetzung auf der basis von wasserstoff enthaltenden chlorfluorkohlenwasserstoffen.
ATE66479T1 (de) 3-methyl-substituierte phenylnaphthyridine und diese enthaltende arzneimittel.
EP0235089A3 (en) N-benzoyl-n'-phenyl ureas, their preparation and their use against pests
DE3867927D1 (de) Guanidin-verbindungen, die ein substituiertes tetraphenylboration enthalten, verfahren zu deren herstellung und verwendung dieser verbindungen waehrend der peptid-synthese.
FI912336A (fi) Omaettade polyesterhartser.
ATE34973T1 (de) Alpha-chlorierte carbonate, ihr herstellungsverfahren und ihre anwendung zum schutz von amingruppen in aminosaeuren.
DK0410278T3 (da) Reninhæmmende aminooligohydroxyderivater
ATE158576T1 (de) Alpha-aryl-alpha-hydroxy-beta- imidazolinylpropionsäureamide
ATE80164T1 (de) Guanidin-verbindungen, die ein tetraphenylboration enthalten, verfahren, um diese zu erhalten und verwendung dieser verbindungen in der peptidsynthese.
DE69127718D1 (de) Galactosamin-substituierte poly-omega-substituierte L-Glutaminsäure und/oder -Asparaginsäure
DE69009224D1 (de) Gem-diamino-Derivate und ihre Verwendung bei der Herstellung von Retro-Inverso-Peptiden.
ES8604925A1 (es) 1-2 procedimiento de preparacion de derivados de 4-fluoro- benzoil-piperidina
TH14328EX (th) L-แอลพาร์ทิล-d-(สัญลักษณ์เคมี)-อะมิโนแอลคาโนอิล-( s )-n-(สัญลักษณ์เคมี)-แอลคิลเบนซิลอะมีด ที่ใช้ประโยชน์เป็นสารททำให้รสหวานชนิดเทียม
ES2095831T3 (es) Acidos tetrahidro-4-fenilimino-3-tiofeno-aceticos.
ES2083961T3 (es) Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee